2seventy bio, Inc. - Common Stock (TSVT)

Historical Holders from Q4 2021 to Q3 2025

Symbol
TSVT on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
52.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-2
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 2seventy bio, Inc. - Common Stock (TSVT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 5.38% $13.9M 2.82M The Vanguard Group 31 Mar 2025
GOLDMAN SACHS GROUP INC 0% $1.54K 308 THE GOLDMAN SACHS GROUP, INC. 30 Jun 2025

Institutional Holders of 2seventy bio, Inc. - Common Stock (TSVT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$508K 0
2025 Q2 96K $508K -$233M $9.92 2
2025 Q1 47.3M $234M +$26.4M $4.94 135
2024 Q4 46M $135M -$4.18M $2.94 115
2024 Q3 45M $212M -$12.1M $4.72 112
2024 Q2 47.6M $183M +$593K $3.85 111
2024 Q1 46.6M $249M -$1.93M $5.35 112
2023 Q4 66.4K $285K +$48.8K $4.27 3
2023 Q3 54.6M $214M -$17.3M $3.92 136
2023 Q2 49.7M $503M -$98K $10.12 142
2023 Q1 49.3M $502M +$169M $10.20 135
2022 Q4 32.7M $306M -$28.8M $9.37 128
2022 Q3 30.3M $442M -$10.4M $14.55 106
2022 Q2 32.1M $423M +$23M $13.20 111
2022 Q1 29.5M $503M +$214M $17.06 109
2021 Q4 17.2M $441M +$441M $25.63 105